Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mansoor

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Medical Economics|February 28, 2012
Elicitation of health state utilities in neuroendocrine tumoursP Swinburn, J Wang, D Chandiwana, et al.
Annals of Clinical Biochemistry|September 28, 2011
A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndromeE Hinchliffe, R L Allcock, W Mansoor, et al.
British Journal of Cancer|October 28, 2005
Engineering T cells for cancer therapyW Mansoor, D E Gilham, F C Thistlethwaite, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 25, 2024
Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified DelphiN P West, W Mansoor, P Taniere, et al.
Clinical Endocrinology|November 27, 2015
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumoursP J Monaghan, A Lamarca, J W Valle, et al.
British Journal of Cancer|September 2, 2005
Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinomaF Donskov, M Middleton, K Fode, et al.
Pancreas|December 13, 2005
A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?Alison J Clayton, Abdul W Mansoor, Eileen T Jones, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 17, 2016
Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumoursV Clay, G Papaxoinis, B Sanderson, et al.
Surgical Oncology|August 28, 2016
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgeryA E Slagter, D Ryder, B Chakrabarty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Medical Economics|February 28, 2012
Elicitation of health state utilities in neuroendocrine tumoursP Swinburn, J Wang, D Chandiwana, et al.
Annals of Clinical Biochemistry|September 28, 2011
A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndromeE Hinchliffe, R L Allcock, W Mansoor, et al.
British Journal of Cancer|October 28, 2005
Engineering T cells for cancer therapyW Mansoor, D E Gilham, F C Thistlethwaite, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 25, 2024
Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified DelphiN P West, W Mansoor, P Taniere, et al.
Clinical Endocrinology|November 27, 2015
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumoursP J Monaghan, A Lamarca, J W Valle, et al.
British Journal of Cancer|September 2, 2005
Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinomaF Donskov, M Middleton, K Fode, et al.
Pancreas|December 13, 2005
A phase II study of weekly cisplatin and gemcitabine in patients with advanced pancreatic cancer: is this a strategy still worth pursuing?Alison J Clayton, Abdul W Mansoor, Eileen T Jones, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 17, 2016
Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumoursV Clay, G Papaxoinis, B Sanderson, et al.
Surgical Oncology|August 28, 2016
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgeryA E Slagter, D Ryder, B Chakrabarty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2017
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplificationE Van Cutsem, Y-J Bang, W Mansoor, et al.
Pageof 2